Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
42.25
+0.76 (1.83%)
At close: Dec 20, 2024, 4:00 PM
42.80
+0.55 (1.30%)
After-hours: Dec 20, 2024, 7:53 PM EST
Viking Therapeutics Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for Viking Therapeutics stock have an average target of 106.75, with a low estimate of 74 and a high estimate of 138. The average target predicts an increase of 152.66% from the current stock price of 42.25.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for VKTX stock from 12 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 8 | 8 |
| Buy | 2 | 2 | 3 | 3 | 3 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 10 | 10 | 11 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $102 | Strong Buy | Reiterates | $102 | +141.42% | Dec 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $102 | Strong Buy | Reiterates | $102 | +141.42% | Dec 18, 2024 |
| Piper Sandler | Piper Sandler | Buy Initiates $74 | Buy | Initiates | $74 | +75.15% | Dec 2, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $102 | Strong Buy | Reiterates | $102 | +141.42% | Nov 27, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $102 | Strong Buy | Reiterates | $102 | +141.42% | Nov 26, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
2.13M
EPS This Year
-0.99
from -0.91
EPS Next Year
-1.51
from -0.99
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | n/a | 26.3M | 200.7M | |||
| Avg | n/a | 2.1M | 22.3M | |||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | 9,346.1% | |||
| Avg | - | - | 950.0% | |||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -0.83 | -1.21 | -0.34 | |||
| Avg | -0.99 | -1.51 | -1.82 | |||
| Low | -1.27 | -2.03 | -2.65 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.